Dr. Johannes Holzmeister is a physician and serial biotech entrepreneur with over 20 years of experience in clinical research and venture building. Trained in cardiology, he held senior roles at Charité – Universitätsmedizin Berlin and the University Hospital Zurich, where he led the heart failure device group. His research has been published in The New England Journal of Medicine, The Lancet, and other top journals. He earned his MD from Humboldt University of Berlin. Johannnes is Co-Founder and majority shareholder of DiNAQOR, a Swiss life science company-building platform. He led the creation of DiNAMIQS, a next-gen gene therapy manufacturing platform, and builds DiNABIOS into a leader in human tissue-based drug discovery and toxicology. At DAiNA, he combines expertise in translational medicine, AI, and oncology to advance personalized cancer therapies.
Johannes Holzmeister, MD
Chairman & Chief Executive Officer, Board